Literature DB >> 23390306

Establishing a quality measurement system for cancer care in Japan.

Takahiro Higashi1, Fumiaki Nakamura, Nobuhiro Saruki, Tomotaka Sobue.   

Abstract

Ensuring the quality of care is a major objective of cancer control policy. The Cancer Control Act 2006 placed responsibility on the Japanese government to maintain the quality of cancer care nationwide. To function as centers providing high-quality care, designated cancer care hospitals (397 hospitals as of April 2012) were instituted nationwide. Although they meet the structural standards, such as the presence of radiation equipment and palliative care teams, it remains unclear whether the designation has led to appropriate provision of care and optimal patient outcomes. A national system to examine the processes and outcomes of cancer care is under development. In 2007 and 2008, the Japanese Association of Clinical Cancer Centers publicly disclosed the 5-year survival of their member facilities with strict data quality standards, including sufficient follow-up of patients' vital status. The network of designated cancer care hospitals will follow this lead to provide a national outcome monitoring system. The processes of care have also been addressed by a government-funded research project. With the collaboration of clinical experts, 206 quality indicators have been developed for five major cancers in Japan (breast, colorectal, liver, lung and stomach) and palliative care. Each indicator described the target patients and standards of care for the patients, the provision of which was considered an aspect of quality. In 2012, the Cancer Registry Chapter of the Association of Prefectural Designated Cancer Care Hospitals instituted quality measurement using these indicators. These activities will soon lead to effective quality monitoring and improvement in Japan.

Entities:  

Mesh:

Year:  2013        PMID: 23390306     DOI: 10.1093/jjco/hyt001

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  9 in total

1.  The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics.

Authors:  Ting-Yuan David Cheng; Susanna M Cramb; Peter D Baade; Danny R Youlden; Chukwumere Nwogu; Mary E Reid
Journal:  J Thorac Oncol       Date:  2016-06-27       Impact factor: 15.609

2.  Evaluating the effect of clinical care pathways on quality of cancer care: analysis of breast, colon and rectal cancer pathways.

Authors:  Han Bao; Fengjuan Yang; Shaofei Su; Xinyu Wang; Meiqi Zhang; Yaming Xiao; Hao Jiang; Jiaying Wang; Meina Liu
Journal:  J Cancer Res Clin Oncol       Date:  2016-01-13       Impact factor: 4.553

3.  Association between compliance with quality indicators and hospitalisation expenses in patients with heart failure: a retrospective study using quantile regression model in China.

Authors:  Rong Fu; Shaodan Feng; Yilong Wu; Fei He; Zheng Lin; Yixian Jiang; Zhijian Hu
Journal:  BMJ Open       Date:  2020-07-23       Impact factor: 2.692

4.  Impact of adherence to board-certified surgeon systems and clinical practice guidelines on colon cancer surgical outcomes in Japan: A questionnaire survey of the National Clinical Database.

Authors:  Hirotoshi Kobayashi; Hiroyuki Yamamoto; Hiroaki Miyata; Mitsukazu Gotoh; Kenjiro Kotake; Kenichi Sugihara; Yasushi Toh; Yoshihiro Kakeji; Yasuyuki Seto
Journal:  Ann Gastroenterol Surg       Date:  2020-04-07

5.  Significance of the board-certified surgeon systems and clinical practice guideline adherence to surgical treatment of esophageal cancer in Japan: a questionnaire survey of departments registered in the National Clinical Database.

Authors:  Yasushi Toh; Hiroyuki Yamamoto; Hiroaki Miyata; Mitsukazu Gotoh; Masayuki Watanabe; Hisahiro Matsubara; Yoshihiro Kakeji; Yasuyuki Seto
Journal:  Esophagus       Date:  2019-04-12       Impact factor: 4.230

6.  Epidemiology and practice patterns for male breast cancer compared with female breast cancer in Japan.

Authors:  Taisuke Ishii; Eriko Nakano; Tomone Watanabe; Takahiro Higashi
Journal:  Cancer Med       Date:  2020-07-01       Impact factor: 4.452

7.  Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer.

Authors:  Rieko Kanehara; Atsushi Goto; Tomone Watanabe; Kosuke Inoue; Masataka Taguri; Satoshi Kobayashi; Kenjiro Imai; Eiko Saito; Kota Katanoda; Motoki Iwasaki; Ken Ohashi; Mitsuhiko Noda; Takahiro Higashi
Journal:  J Diabetes Investig       Date:  2022-06-04       Impact factor: 3.681

8.  Monitoring and evaluating the quality of cancer care in Japan using administrative claims data.

Authors:  Momoko Iwamoto; Fumiaki Nakamura; Takahiro Higashi
Journal:  Cancer Sci       Date:  2015-11-30       Impact factor: 6.716

9.  Matters of data openness and KapWeb, a web tool of multi-cancer survival analysis for cancer survivors.

Authors:  Jason Lin; Yohko Nakamura; Haruo Mikami; Miho Kusakabe; Nobuhiro Saruki; Fumihiko Wakao; Hiroki Nagase
Journal:  Cancer Sci       Date:  2021-03-10       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.